Supergenics Berhad (KLSE:SGBHD)
Malaysia · Delayed Price · Currency is MYR 0.2500
+0.0450 (21.95%)
At close: Dec 30, 2025
Supergenics Berhad Income Statement
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4.74 | 5.63 | 5.32 | 10.24 | 10.72 | 9.47 | |
Revenue Growth | -25.89% | 5.70% | -48.02% | -4.47% | 13.13% | 84.46% |
Cost of Revenue | 5.06 | 4.25 | 3.42 | 5.59 | 6.94 | 7.51 |
Gross Profit | -0.32 | 1.37 | 1.9 | 4.65 | 3.78 | 1.96 |
Selling, General & Admin | 4.84 | 4.51 | 4.48 | 3.66 | 2.81 | 2.53 |
Other Operating Expenses | -0.52 | -0.48 | -0.27 | -0.42 | -0.19 | -0.15 |
Operating Expenses | 4.77 | 4.48 | 9.26 | 3.11 | 2.59 | 2.29 |
Operating Income | -5.09 | -3.11 | -7.36 | 1.53 | 1.19 | -0.33 |
Interest Expense | -0.39 | -0.41 | -0.42 | -0.42 | -0.36 | -0.36 |
Interest & Investment Income | - | - | - | - | - | 0.05 |
Earnings From Equity Investments | - | - | -0.03 | -0.15 | -0.06 | - |
EBT Excluding Unusual Items | -5.48 | -3.52 | -7.81 | 0.97 | 0.77 | -0.64 |
Gain (Loss) on Sale of Investments | - | - | - | - | - | 0.03 |
Gain (Loss) on Sale of Assets | 0.1 | 0.1 | - | - | - | - |
Pretax Income | -5.38 | -3.42 | -7.81 | 0.97 | 0.77 | -0.61 |
Income Tax Expense | 0.01 | 0.01 | -0.12 | 0.82 | 0.43 | -0.07 |
Earnings From Continuing Operations | -5.39 | -3.43 | -7.69 | 0.15 | 0.35 | -0.54 |
Minority Interest in Earnings | 0.07 | 0.06 | 0.41 | 0.03 | - | - |
Net Income | -5.32 | -3.37 | -7.28 | 0.18 | 0.35 | -0.54 |
Net Income to Common | -5.32 | -3.37 | -7.28 | 0.18 | 0.35 | -0.54 |
Net Income Growth | - | - | - | -48.85% | - | - |
Shares Outstanding (Basic) | 116 | 116 | 115 | 94 | 93 | 93 |
Shares Outstanding (Diluted) | 116 | 116 | 115 | 94 | 93 | 93 |
Shares Change | 100.17% | 1.02% | 21.74% | 1.32% | - | 0.29% |
EPS (Basic) | -0.05 | -0.03 | -0.06 | 0.00 | 0.00 | -0.01 |
EPS (Diluted) | -0.05 | -0.03 | -0.06 | 0.00 | 0.00 | -0.01 |
EPS Growth | - | - | - | -49.54% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | 0.4 | -3.06 | -2.26 | -0.34 | -0.91 |
Free Cash Flow Per Share | - | 0.00 | -0.03 | -0.02 | -0.00 | -0.01 |
Gross Margin | -6.71% | 24.41% | 35.79% | 45.41% | 35.27% | 20.74% |
Operating Margin | -107.35% | -55.24% | -138.25% | 14.99% | 11.12% | -3.44% |
Profit Margin | -112.20% | -59.83% | -136.81% | 1.73% | 3.23% | -5.75% |
Free Cash Flow Margin | - | 7.05% | -57.59% | -22.11% | -3.19% | -9.65% |
EBITDA | -4.15 | -2.26 | -6.68 | 2.15 | 1.76 | 0.22 |
EBITDA Margin | -87.55% | -40.25% | -125.44% | 20.98% | 16.45% | 2.31% |
D&A For EBITDA | 0.94 | 0.84 | 0.68 | 0.61 | 0.57 | 0.54 |
EBIT | -5.09 | -3.11 | -7.36 | 1.53 | 1.19 | -0.33 |
EBIT Margin | -107.35% | -55.24% | -138.25% | 14.99% | 11.12% | -3.44% |
Effective Tax Rate | - | - | - | 84.74% | 55.16% | - |